Tanja Auth

Tanja Auth is a seasoned professional in the biopharmaceutical industry with extensive experience in CMC (Chemistry, Manufacturing, and Controls) for mRNA and CAR-T cell therapies. Currently serving as Senior Director CMC and Portfolio Lead at BioNTech SE, Tanja Auth focuses on defining long-term strategies and managing a team responsible for therapeutic and vaccine development. Previously, Tanja Auth held positions including Director CMC at BioNTech SE, Manager Operations at Eurofins BioPharma Product Testing, and Director of Translational R&D and Manufacturing at Calidi Biotherapeutics, where responsibilities spanned team leadership, drug development strategy, and process optimization. Academic credentials include a PhD and a Diplom in Biochemistry and Chemistry from The Julius Maximilians University of Würzburg.